Key result
Paced electrogram fractionation analysis (PEFA) is an emerging technique that shows promise in identifying high-risk patients with hypertrophic cardiomyopathy and other non-coronary heart diseases.
Why the study?
Does paced electrogram fractionation analysis (PEFA) predict sudden arrhythmic death in patients with hypertrophic cardiomyopathy?
Does paced electrogram fractionation analysis (PEFA) predict sudden arrhythmic death in patients with hypertrophic cardiomyopathy?
Paced electrogram fractionation analysis (PEFA) is a promising emerging technique for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
PEFA may refine SCD risk stratification in HCM; leaves open prospective validation before clinical adoption.
Richard C. Saumarez (2000) conducted a review in Hypertrophic cardiomyopathy and other non-coronary heart diseases. Paced electrogram fractionation analysis (PEFA) was evaluated on Sudden arrhythmic death (SCD). Paced electrogram fractionation analysis (PEFA) is an emerging technique that shows promise in identifying high-risk patients with hypertrophic cardiomyopathy and other non-coronary heart diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: